Event descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo has expanded further, with Dungu Health Zone in Haut-Uélé Province, bordering South Sudan, being the latest affected, b…
Ler maisEvent descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo has expanded to a seventh province, with the first confirmed case reported in Bulu Health Zone, Sud-Ubangi, a province …
Ler maisEvent descriptionThe epidemiological pattern of the Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo is becoming increasingly heterogeneous, with divergent transmission trends across affect…
Ler maisEvent descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo continues to evolve, characterized by sustained transmission, high mortality and continued geographic expansion. The ep…
Ler maisEvent descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo has expanded to a sixth province, with the detection of a confirmed case in Bas-Uélé province in the north-east, indica…
Ler maisEvent descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo remains in a phase of intense and expanding transmission, with cumulative deaths crossing the grim milestone of 2,000 o…
Ler maisEvent descriptionThe Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo continues to expand rapidly, with sustained transmission, persistently high mortality, and ongoing geographic spread. I…
Ler maisWHO's updated guidelines set out treatment recommendations for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL) in eastern Africa and South-East Asia, the subregion that accounted for 73% of VL cases reported globally to WHO in 2023. They introduce new treatment regimens for PKDL, alternative options for primary VL in eastern Africa, weight-band allometric dosing of miltefosine, and risk-mitigation measures following reports of ocular adverse events.
Ler mais
Uganda — Publicações